Joseph Rosado
Lake Erie College of Osteopathic Medicine, USA
Title: Medical Cannabis for Alzheimer’s Diseases-Is it An Option?
Biography
Biography: Joseph Rosado
Abstract
BACKGROUND: Alzheimer's disease (AD) is a progressive and irreversible brain disorder that slowly destroys memory and thinking skills and eventually the ability to carry out the simplest tasks. Currently, it ranks as the sixth leading cause of death in the United States and the fourth leading cause of death on the island of Puerto Rico and Colombia.
Medical cannabis is now a part of contemporary medicine, with physicians recommending a medical card in 33 states and two territories in the United States of America, for physiological conditions such as vomiting, migraines, multiple sclerosis, glaucoma, nausea, cell disease sickle cell disease, Parkinson's disease, sleep apnea, spinal cord injury, arthritis, Alzheimer's disease, muscle spasms, and asthma, as well as psychological conditions such as anxiety disorder, insomnia, bipolar disorder, depression, and post-traumatic stress disorder.
DESIGN/METHODS: A literature review was conducted of the National Center for Biotechnology Information, U.S. National Library of Medicine PubMed from 2001-2019 specific to the topic of Alzheimer’s Disease and Medical Cannabis/Medical Marijuana/CBD/THC.
RESULTS: Phytocannabinoid treatment can restore cognition in older animals and induce molecular changes that make them more similar to young animals.
CONCLUSION: The inherent polypharmaceutical properties of cannabis botanicals offer distinct advantages over the current single-target pharmaceutical model and heralds revolutionizing neurological treatment into a new reality of effective and even preventative interventional treatment and studies show that cannabis extracts can be used in safe way to improve symptoms of severe dementia.